PharmaCyte Biotech, Inc. Announces Reverse Stock Split
Nov 11, 2026, 9:43 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
A reverse split is a governance action that reduces outstanding share count and can affect per-share metrics and listing compliance; the economic impact on revenue or cash is indirect and depends on the split ratio and any related filings.
AI summary
What happened, with direct paths to the underlying reporting
PharmaCyte Biotech announced a reverse stock split.
PharmaCyte Biotech, Inc. announces a reverse stock split.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event